SANDERLING IV BIOMEDICAL L P
SANDERLING IV BIOMEDICAL L P — US company (sec:0001040897). 1 holding. Every claim linked to its source.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
None in current sources.
- SANDERLING IV BIOMEDICAL L P
Nothing further is withheld here. The ownership and control links above are everything we have resolved for SANDERLING IV BIOMEDICAL L P — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.
Coverage of SANDERLING IV BIOMEDICAL L P is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.
Explore US coverage4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
Nothing further on SANDERLING IV BIOMEDICAL L P is behind a paywall — everything we hold on this subject is already on this page.
People & control
1 party · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- CARDIONET INCAlso holds roles at 49 other companies
- RUBIN ROBERT J.director
- GORMAN KIRK Edirector
- RIMEL REBECCA Wdirector
1 party · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns SANDERLING IV BIOMEDICAL L P?
- What is SANDERLING IV BIOMEDICAL L P's risk level?
- Where does SANDERLING IV BIOMEDICAL L P appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for SANDERLING IV BIOMEDICAL L P — nothing is disclosed before that.